A study of the return on investment (ROI) in various pharmaceutical promotional strategies may result in a shift of money away from expensive detailing and direct-to-consumer advertising and toward meetings and journal advertising — if pharmaceutical companies take its results to heart.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments
